Investment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital Heidelberg
TOKYO, April 23, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced…
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds
April 07, 2025 17:21 ET | Source: Bluejay Diagnostics, Inc. ACTON, Mass.,…
OMNICOM MEDIA GROUP AGENCY OMD TAKES TOP SLOT IN RECMA DIAGNOSTICS REPORT FOR NINTH CONSECUTIVE EDITION, REINFORCING ITS LEAD IN THE MARKETPLACE
NEW YORK, March 20, 2025 /PRNewswire/ -- In the latest edition of…
Pearl Partners with Medit to Enhance AI-Powered Dental Diagnostics in Intraoral Scanning and Medit Link Software Platform
By integrating Pearl's AI-powered diagnostic solutions with Medit Link, dental clinicians will gain…
Total Investment of Approx. USD 11.4 Million in Schistosomiasis Diagnostics and R&D Projects for NTDs With Partners Including Drugs & Diagnostics for Tropical Diseases and Medical & Biological Laboratories
TOKYO, March 18, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced…
A Total of USD 12.7 Million Investment in New Diagnostics and Drug Development for NTDs and Malaria to Partners Including the Ohio State University, PATH, GSK and Others
TOKYO, Jan. 30, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced…
CrisprBits opens Research and Innovation Centre for CRISPR Gene Editing and Diagnostics in Bengaluru
BENGALURU, India, Jan. 16, 2025 /PRNewswire/ -- Bengaluru-based biotechnology startup, CrisprBits Private…
CrisprBits opens Research and Innovation Centre for CRISPR Gene Editing and Diagnostics in Bengaluru
BENGALURU, India, Jan. 16, 2025 /PRNewswire/ -- Bengaluru-based biotechnology startup, CrisprBits Private…
Effective 02/07/2025, Interpace Diagnostics to No Longer Offer PancraGEN, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk
PARSIPPANY, NJ, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary…
Roche transforms mass spectrometry diagnostics with launch of cobas Mass Spec solution
December 18, 2024 01:00 ET | Source: F. Hoffmann-La Roche Ltd Roche…